logo

For the Inventor, By the Inventor

Nashville, TN, United States of America

Cumberland Pharmaceuticals, Inc.


USPTO Granted Patents = 32

% Expired Patents = 18.8



Trademarks = 17

Forward Citations = 121

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Leo Pavliv (31 out of 38 patents)

silverMedal Amy Dix Rock (9 out of 9 patents)

bronzeMedal Bryan Voss (8 out of 9 patents)

4.  James West (7 out of 11 patents)

5.  Erica J Carrier (7 out of 9 patents)

6.  Andrew Vila (6 out of 6 patents)

7.  Steven L Barriere (1 out of 1 patent)

8.  Arthur Lo (1 out of 1 patent)

9.  Philip Worboys (1 out of 1 patent)

10.  Ines Macias-Perez (1 out of 2 patents)

11.  Mathai Mammen (1 out of 104 patents)

12.  Nicholas A Haglund (0 patent)

13.  Pavliv Leo (0 patent)

14.  Zachary Cox (2 patents)


Core Competencies:
Cardiac Fibrosis
Ifetroban
Ibuprofen
Thromboxane Receptor
AERD
Telavancin
Stabilized Statins
Lactulose
Acetylcysteine
Intravenous Administration
Pharmaceutical Composition

32 patents:

1. 12161632 - Compositions and methods of treating cardiac fibrosis with ifetroban (2024-12-10),
2. 11806400 - Injectable ibuprofen formulation (2023-11-07),
3. 11571412 - Thromboxane receptor antagonists in AERD/asthma (2023-02-07),
4. 10925860 - Compositions and methods of treating cardiac fibrosis with ifetroban (2021-02-23),
5. 10751383 - Doses and methods for administering telavancin (2020-08-25),
6. 10583126 - Compositions and methods of treating cardiac fibrosis with ifetroban (2020-03-10),
7. 10314824 - Compositions and methods of treating cardiac fibrosis with ifetroban (2019-06-11),
8. 10064845 - [object Object] (2018-09-04),
9. 10016399 - Compositions and methods of treating cardiac fibrosis with ifetroban (2018-07-10),
10. 9931311 - Treating critically ill patients with intravenous ibuprofen (2018-04-03),
11. 9820966 - Stabilized statin formulations (2017-11-21),
12. 9693998 - Compositions and methods of treating cardiac fibrosis with ifetroban (2017-07-04),
13. 9649284 - Treating critically ill patients with intravenous ibuprofen (2017-05-16),
14. 9375441 - Lactulose for bowel evacuation (2016-06-28),
15. 9327028 - Acetylcysteine compositions and methods of use thereof (2016-05-03),
Company Overview
Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company based in Nashville, Tennessee, focused on developing and commercializing innovative products for the treatment of various medical conditions. The company specializes in areas such as pain management, critical care, and infectious diseases, aiming to address unmet medical needs through its proprietary formulations. With a commitment to improving patient outcomes, Cumberland leverages its expertise in drug development and regulatory processes to bring effective therapies to market.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

32 Patents

#19 in Nashville, TN

#98 in Tennessee

#10,599 in US

#20,671 in the World

Nashville, TN (US)
Nashville, TN, United States of America

Cumberland Pharmaceuticals, Inc.

Forward Citations = 121

11 inventors:

goldMedal Leo Pavliv (31 out of 38 patents)

silverMedal Amy Dix Rock (9 out of 9 patents)

bronzeMedal Bryan Voss (8 out of 9 patents)

4.  James West (7 out of 11 patents)

5.  Erica J Carrier (7 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cumberland Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/cumberland-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…